Clinical Trial Update: Study of [S,S]-Reboxetine in Patients With Postherpetic Neuralgia, Who Are Gabapentin Treatment Failures [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating S,S-Reboxetine for postherpetic neuralgia in gabapentin-treatment failures has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postherpetic Neuralgia

Drugs mentioned

• S,S-Reboxetine (reboxetine)

Snippet

Sponsor: Pfizer | Conditions: Pain | Phase 2 | Status: COMPLETED